{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:54:36Z","timestamp":1771581276356,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.chroma.2018.07.018","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T13:56:43Z","timestamp":1530799003000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer\u2019s disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry"],"prefix":"10.1016","volume":"1568","author":[{"given":"San Ha","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Seon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Cheol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5893-3124","authenticated-orcid":false,"given":"Jun-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eosu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5454-2601","authenticated-orcid":false,"given":"Myeong Hee","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2018.07.018_bib0005","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-B-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.chroma.2018.07.018_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00102","article-title":"Alzheimer\u2019s disease: biomarkers in the genome, blood, and cerebrospinal fluid","volume":"8","author":"Huynh","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.chroma.2018.07.018_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00063","article-title":"APP function and lipids: a bidirectional link","volume":"10","author":"Grimm","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.chroma.2018.07.018_bib0020","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm0896-850","article-title":"New clues to Alzheimer\u2019s disease: unraveling the roles of amyloid and tau","volume":"2","author":"Yankner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.chroma.2018.07.018_bib0025","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chroma.2018.07.018_bib0030","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.chroma.2018.07.018_bib0035","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00415-012-6694-0","article-title":"Supporting evidence for using biomarkers in the diagnosis of MCI due to AD","volume":"260","author":"Galluzzi","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.chroma.2018.07.018_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029868","article-title":"Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer\u2019s disease","volume":"7","author":"Bj\u00f6rkqvist","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.chroma.2018.07.018_bib0045","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","article-title":"Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins","volume":"13","author":"Ray","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.chroma.2018.07.018_bib0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1468-1331.2003.00562.x","article-title":"CSF tau protein and \u03b2-amyloid (1-42) in Alzheimer\u2019s disease diagnosis: discrimination from normal ageing and other dementias in the Greek population","volume":"10","author":"Kapaki","year":"2003","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.chroma.2018.07.018_bib0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","article-title":"Identifying and validating biomarkers for Alzheimer\u2019s disease","volume":"29","author":"Humpel","year":"2011","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.chroma.2018.07.018_bib0060","doi-asserted-by":"crossref","first-page":"42751","DOI":"10.1074\/jbc.M112.380642","article-title":"Extracellular tau levels are influenced by variability in tau that is associated with tauopathies","volume":"287","author":"Karch","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chroma.2018.07.018_bib0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.chroma.2018.07.018_bib0070","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jalz.2014.05.1749","article-title":"Plasma proteins predict conversion to dementia from prodromal disease","volume":"10","author":"Hye","year":"2014","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.chroma.2018.07.018_bib0075","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/brain\/awl279","article-title":"Proteome-based plasma biomarkers for Alzheimer\u2019s disease","volume":"129","author":"Hye","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.chroma.2018.07.018_bib0080","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0698-730","article-title":"A detergent-insoluble membrane compartment contains A\u03b2 in vivo","volume":"4","author":"Lee","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.chroma.2018.07.018_bib0085","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0960-9822(01)00394-3","article-title":"Compartmentalization of \u03b2-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts","volume":"11","author":"Riddell","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.chroma.2018.07.018_bib0090","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1046\/j.1471-4159.2001.00332.x","article-title":"Plasmalogen deficiency in early Alzheimer\u2019s disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry","volume":"77","author":"Han","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.chroma.2018.07.018_bib0095","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","article-title":"Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer\u2019s disease: potential role in disease pathogenesis","volume":"82","author":"Han","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.chroma.2018.07.018_bib0100","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-150336","article-title":"Targeted lipidomics of fontal cortex and plasma diacylglycerols (DAG) in mild cognitive impairment and Alzheimer\u2019s disease: validation of DAG accumulation early in the pathophysiology of Alzheimer\u2019s disease","volume":"48","author":"Wood","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.chroma.2018.07.018_bib0105","first-page":"1","article-title":"Association of blood lipids with Alzheimer\u2019s disease: a comprehensive lipidomics analysis","volume":"13","author":"Proitsi","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.chroma.2018.07.018_bib0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1006\/bbrc.1998.9652","article-title":"Elevated low-density lipoprotein in Alzheimer\u2019s disease correlates with brain a\u03b2 1-42 levels","volume":"252","author":"Kuo","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chroma.2018.07.018_bib0115","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/1044-0305(95)00568-4","article-title":"Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry","volume":"6","author":"Han","year":"1995","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.chroma.2018.07.018_bib0120","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1083\/jcb.146.4.741","article-title":"Electrospray ionization tandem mass spectrometry (ESI-MS\/MS) analysis of the lipid molecular species composition of yeast subcellular membranes reveals acyl chain-based sorting\/remodeling of distinct molecular species en route to the plasma membrane","volume":"146","author":"Schneiter","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.chroma.2018.07.018_bib0125","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/1096-9888(200008)35:8<953::AID-JMS23>3.0.CO;2-4","article-title":"Two-dimensional analysis of phospholipids by capillary liquid chromatography\/electrospray ionization mass spectrometry","volume":"35","author":"Taguchi","year":"2000","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.chroma.2018.07.018_bib0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0165-0270(03)00168-7","article-title":"Analysis of phosphatidylcholine and sphingomyelin molecular species from brain extracts using capillary liquid chromatography electrospray ionization mass spectrometry","volume":"128","author":"Isaac","year":"2003","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.chroma.2018.07.018_bib0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/ac403554h","article-title":"Analytical methods in lipidomics and their applications","volume":"86","author":"Li","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2018.07.018_bib0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.trac.2014.04.017","article-title":"Comprehensive analysis of lipids in biological systems by liquid chromatography\u2013mass spectrometry","volume":"61","author":"Cajka","year":"2014","journal-title":"TrAC\u2014Trends Anal. Chem."},{"key":"10.1016\/j.chroma.2018.07.018_bib0145","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1194\/jlr.M500506-JLR200","article-title":"LC\u2013MS-based method for the qualitative and quantitative analysis of complex lipid mixtures","volume":"47","author":"Sommer","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chroma.2018.07.018_bib0150","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1021\/acs.analchem.5b01054","article-title":"High-throughput and comprehensive lipidomic analysis using ultrahigh-performance supercritical fluid chromatography-mass spectrometry","volume":"87","author":"L\u00edsa","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2018.07.018_bib0155","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1194\/jlr.D007567","article-title":"Lipid profiling of rat peritoneal surface layers by online normal- and reversed-phase 2D LC QToF-MS","volume":"51","author":"Nie","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chroma.2018.07.018_bib0160","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1007\/s00216-016-9592-y","article-title":"High-throughput and rapid quantification of lipids by nanoflow UPLC-ESI-MS\/MS: application to the hepatic lipids of rabbits with nonalcoholic fatty liver disease","volume":"408","author":"Byeon","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2018.07.018_bib0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.chroma.2015.05.059","article-title":"Top-down and bottom-up lipidomic analysis of rabbit lipoproteins under different metabolic conditions using flow field-flow fractionation, nanoflow liquid chromatography and mass spectrometry","volume":"1405","author":"Byeon","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2018.07.018_bib0170","article-title":"Evaluation of treadmill exercise effect on muscular lipid profiles of diabetic fatty rats by nanoflow liquid chromatography-tandem mass spectrometry","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chroma.2018.07.018_bib0175","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1021\/ac503973p","article-title":"Profiling of oxidized phospholipids in lipoproteins from patients with coronary artery disease by hollow fiber flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry","volume":"87","author":"Lee","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2018.07.018_bib0180","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0140-6736(91)92823-K","article-title":"Apolipoprotein E genotyping by one-stage PCR","volume":"337","author":"Wenham","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.chroma.2018.07.018_bib0185","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.chroma.2018.07.018_bib0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1017\/S1355617704101094","article-title":"A normative study of the CERAD neuropsychological assessment battery in the Korean elderly","volume":"10","author":"Lee","year":"2004","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.chroma.2018.07.018_bib0195","doi-asserted-by":"crossref","first-page":"P47","DOI":"10.1093\/geronb\/57.1.P47","article-title":"Development of the Korean version of the consortium to establish a registry for Alzheimer\u2019s disease assessment packet (CERAD-K): clinical and neuropsychological assessment batteries","volume":"57","author":"Lee","year":"2002","journal-title":"J. Gerontol. Ser. B: Psychol. Sci. Soc. Sci."},{"key":"10.1016\/j.chroma.2018.07.018_bib0200","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer\u2019s disease","volume":"39","author":"Moms","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.chroma.2018.07.018_bib0205","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.chroma.2018.07.018_bib0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S1041610297004717","article-title":"Aging, memory, and mild cognitive impairment","volume":"9","author":"Petersen","year":"1997","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.chroma.2018.07.018_bib0215","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates","volume":"55","author":"Scheltens","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.chroma.2018.07.018_bib0220","first-page":"421","article-title":"MR signal abnormalities at 1.5\u202fT in Alzheimer\u2019s dementia and normal aging","volume":"8","author":"Fazekas","year":"1987","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.chroma.2018.07.018_bib0225","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1039\/C1AN15920H","article-title":"Optimized extraction of phospholipids and lysophospholipids for nanoflow liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"137","author":"Byeon","year":"2012","journal-title":"Analyst"},{"key":"10.1016\/j.chroma.2018.07.018_bib0230","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/jms.3033","article-title":"Computational approach to structural identification of phospholipids using raw mass spectra from nanoflow liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"47","author":"Lim","year":"2012","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.chroma.2018.07.018_bib0235","doi-asserted-by":"crossref","first-page":"51451","DOI":"10.1074\/jbc.M404635200","article-title":"Fibrillar amyloid-\u03b2 peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase: implications for Alzheimer\u2019s disease","volume":"279","author":"Jana","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chroma.2018.07.018_bib0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.chroma.2018.07.018_bib0245","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.physbeh.2007.12.002","article-title":"Muscular diacylglycerol metabolism and insulin resistance","volume":"94","author":"Timmers","year":"2008","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.chroma.2018.07.018_bib0250","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.chroma.2018.07.018_bib0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1474-9726.2011.00760.x","article-title":"Alterations in phosphatidylethanolamine levels affect the generation of A\u03b2","volume":"11","author":"Nesic","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.chroma.2018.07.018_bib0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamaneurol.2013.5390","article-title":"Associations between serum cholesterol levels and cerebral amyloidosis","volume":"71","author":"Reed","year":"2014","journal-title":"JAMA Neurol."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967318308604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967318308604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T17:53:14Z","timestamp":1762192394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967318308604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":52,"alternative-id":["S0021967318308604"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2018.07.018","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer\u2019s disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2018.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}